Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Intratumoral delivery of IL-12 and IL-27 mRNA using lipid nanoparticles for cancer immunotherapy

Journal of Controlled Release(2022)10.1016/j.jconrel.2022.03.021Source: DataRank Database

Intratumoral delivery of IL-12 and IL-27 mRNA using lipid nanoparticles for cancer immunotherapy is a research paper published in Journal of Controlled Release (2022). On theSindex it has a DataRank of 0. It has been cited 246 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access246 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 15.91)OA: greenTopics (46)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Chengxiang Zhang ORCID,Xinfu Zhang ORCID,Jinyue Yan ORCID,Chunxi Zeng ORCID,Fatemeh Talebian ORCID

Live enrichment

PubMed:35301053 PMC:PMC9133152 OpenAlex:https://openalex.org/W4220663685

National Institutes of Health

Grant: R35GM119679

National Cancer Institute

Grant: R01CA229254

NCI NIH HHS

Grant: P30 CA016058

National Institutes of Health

Grant: 5R35GM119679-02

Cell-specific and multifunctional drug formulations for in vivo delivery

National Institutes of Health

Grant: 5R01CA229254-03

IL-27 as a potential immunotherapeutic for cancer

National Institute of General Medical Sciences

FWCI

15.91

Citation Percentile

1.0%

Influential Citations

Citation Trend

2022

2023

2024

2025

2026

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9133152

BRONZEhttps://www.sciencedirect.com/science/article/am/pii/S016836592200147X

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9133152

publisherhttps://api.elsevier.com/content/article/PII:S016836592200147X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S016836592200147X?httpAccept=text/plain

Fields of Study

Immunotherapy and Immune ResponsesCAR-T cell therapy researchImmune Cell Function and InteractionMedicine0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

HumansImmunotherapyLiposomesNeoplasmsRNA, MessengerGranulocyte-Macrophage Colony-Stimulating FactorCytokinesCD8-Positive T-LymphocytesInterleukin-12NanoparticlesInterleukin-27

Keywords

Immune systemImmunotherapyIn vivoCancer immunotherapyCancer researchCytokineCD8MelanomaSystemic administrationIn vitroChemistryMedicinePharmacologyImmunologyBiologyBiochemistryCytokinesMrna TherapeuticsDiamino Lipid-derived Nanoparticles (Dal-lnps)Interleukin-27Granulocyte-Macrophage Colony-Stimulating FactorCD8-Positive T-LymphocytesInterleukin-12NeoplasmsLiposomesHumansNanoparticlesRNA, Messenger

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being